Bulk Manufacturer of Controlled Substances Registration, 52908-52909 [2016-18921]

Download as PDF 52908 Federal Register / Vol. 81, No. 154 / Wednesday, August 10, 2016 / Notices replace the volume of articles potentially subject to the recommended orders within a commercially reasonable time; and (v) explain how the recommended orders would impact consumers in the United States. Written submissions must be filed no later than by close of business on September 6, 2016. Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to Commission Rule 210.4(f), 19 CFR 210.4(f). Submissions should refer to the investigation number (‘‘Inv. No. 947’’) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, http:// www.usitc.gov/secretary/fed_reg_ notices/rules/handbook_on_electronic_ filing.pdf). Persons with questions regarding filing should contact the Secretary, (202) 205–2000. Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel, solely for cybersecurity purposes. All contract personnel will sign appropriate nondisclosure agreements. All non-confidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). Company mstockstill on DSK3G9T082PROD with NOTICES The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance 17:34 Aug 09, 2016 Jkt 238001 [FR Doc. 2016–18904 Filed 8–9–16; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: Notice of registration. Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as an importer of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. SUMMARY: FR Docket Mylan Pharmaceuticals, Inc. ................................................... Hospira .................................................................................... Cambrex Charles City ............................................................ Pharmacore ............................................................................ Mallinckrodt LLC ..................................................................... Meda Pharmaceuticals, Inc. ................................................... Stepan Company .................................................................... VerDate Sep<11>2014 By order of the Commission. Issued: August 4, 2016. Lisa R. Barton, Secretary to the Commission. 80 81 81 81 81 81 81 FR FR FR FR FR FR FR Published 75691 .......................................................................... 1208 ............................................................................ 14892 .......................................................................... 15565 .......................................................................... 15566 .......................................................................... 15560 .......................................................................... 20417 .......................................................................... with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: August 2, 2016. Louis J. Milione, Deputy Assistant Administrator. Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances. SUMMARY: The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices. SUPPLEMENTARY INFORMATION: [FR Doc. 2016–18922 Filed 8–9–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: PO 00000 Notice of registration. Frm 00099 Fmt 4703 Sfmt 4703 December 3, 2015. January 11, 2016. March 18, 2016. March 23, 2016. March 23, 2016. March 23, 2016. April 7, 2016 E:\FR\FM\10AUN1.SGM 10AUN1 52909 Federal Register / Vol. 81, No. 154 / Wednesday, August 10, 2016 / Notices Company FR Docket Noramco, Inc. .......................................................................................... Cayman Chemical Company .................................................................. Janssen Pharmaceutical, Inc. ................................................................. Insys Therapeutics, Inc. .......................................................................... Siemens Healthcare Diagnostics, Inc. .................................................... Siegfried USA, LLC ................................................................................. Patheon Pharmaceuticals, Inc. ............................................................... Navinta, LLC ............................................................................................ Patheon API Manufacturing, Inc. ............................................................ The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed persons. Dated: August 2, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–18921 Filed 8–9–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE mstockstill on DSK3G9T082PROD with NOTICES Notice of Lodging Proposed Consent Decree In accordance with Departmental Policy, 28 CFR 50.7, notice is hereby given that a proposed Consent Decree in Dan Eoff v. United States Environmental Protection Agency, Civil Action No. 4:13–cv–00368–DPM, was lodged with the United States District Court for the Eastern District of Arkansas, Western Division, on August 4, 2016. This proposed Consent Decree concerns a complaint filed by Plaintiff and Counterclaim Defendant Dan Eoff against the United States Environmental Protection Agency, and an answer and counterclaim filed by the United States, on behalf of the United States Environmental Protection Agency, against Dan Eoff pursuant to Section 301(a) of the Clean Water Act, to obtain injunctive relief from and impose civil penalties against the Plaintiff and Counterclaim Defendant for violating VerDate Sep<11>2014 17:34 Aug 09, 2016 Jkt 238001 81 81 81 81 81 81 81 81 81 FR FR FR FR FR FR FR FR FR 7587 .................................... 9217 .................................... 9219 .................................... 9220 .................................... 15565 .................................. 15567 .................................. 15571 .................................. 20418 .................................. 22122 .................................. the Clean Water Act by discharging pollutants without a permit into waters of the United States. The proposed Consent Decree resolves these allegations by requiring Mr. Eoff to restore the impacted areas, perform mitigation and pay a civil penalty. The Department of Justice will accept written comments relating to this proposed Consent Decree for thirty (30) days from the date of publication of this Notice. Please address comments to Lisa Bell, Trial Attorney and John E. Sullivan, Trial Attorney for the United States Department of Justice, Environment and Natural Resources Division, Environmental Defense Section, Post Office Box 7611, Washington, DC 20044 and refer to Dan Eoff v. United States Environmental Protection Agency, DJ # 90–5–1–4– 19920. The proposed Consent Decree may be examined at the Clerk’s Office, United States District Court for the Eastern District of Arkansas, Western Division, 600 West Capitol Avenue, Suite A149, Little Rock, AR 72201. In addition, the proposed Consent Decree may be examined electronically at http:// www.justice.gov/enrd/consent-decrees. Cherie L. Rogers, Assistant Section Chief, Environmental Defense Section, Environment and Natural Resources Division. [FR Doc. 2016–18933 Filed 8–9–16; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Consent Decree Under the Clean Water Act On August 4, 2016, the Department of Justice lodged a proposed Consent Decree with the United States District Court for the Western District of Pennsylvania in the lawsuit entitled United States and the Pennsylvania Department of Environmental Protection v. CONSOL Energy Inc., et al., Civil Action No. 2:16–CV–01178. The proposed Consent Decree will resolve Clean Water Act and associated PO 00000 Frm 00100 Fmt 4703 Published Sfmt 4703 February 12, 2016. February 24, 2016. February 24, 2016. February 24, 2016. March 23, 2016. March 23, 2016. March 23, 2016. April 7, 2016. April 14, 2016. state claims alleged in this action by the United States and the Pennsylvania Department of Environmental Protection Against CONSOL Energy Inc., CNX Coal Resources LP, and Consol Pennsylvania Coal Company LLC for the discharge of pollutants from the Bailey Mine Complex in Greene and Washington Counties, Pennsylvania, into state waters and waters of the United States in violation of limits in National Pollutant Discharge Elimination System (‘‘NPDES’’) permits. Under the proposed Consent Decree, Defendants will perform injunctive relief including implementing water management measures to prevent contaminated discharge, conducting long-term monitoring to ensure sufficient storage capacity to prevent future discharges, developing contingency plans should future discharges become likely, and implementing an environmental management system to ensure compliance with the Clean Water Act and other applicable environmental laws. In addition, Defendants will pay a total civil penalty of $3 million in three installments, with the last payment on January 15, 2018. The publication of this notice opens a period for public comment on the Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States and the Pennsylvania Department of Environmental Protection v. CONSOL Energy Inc. et al., D.J. Ref. No. 90–5–1–1–10614. All comments must be submitted no later than thirty (30) days after the publication date of this notice. Comments may be submitted either by email or by mail: To submit comments: Send them to: By email ....... pubcommentees.enrd@usdoj.gov. Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. By mail ......... E:\FR\FM\10AUN1.SGM 10AUN1

Agencies

[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Pages 52908-52909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18921]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by-the Drug Enforcement Administration (DEA) as bulk 
manufacturers of various classes of controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as manufacturers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted for these 
notices.

[[Page 52909]]



------------------------------------------------------------------------
             Company                   FR Docket           Published
------------------------------------------------------------------------
Noramco, Inc....................  81 FR 7587........  February 12, 2016.
Cayman Chemical Company.........  81 FR 9217........  February 24, 2016.
Janssen Pharmaceutical, Inc.....  81 FR 9219........  February 24, 2016.
Insys Therapeutics, Inc.........  81 FR 9220........  February 24, 2016.
Siemens Healthcare Diagnostics,   81 FR 15565.......  March 23, 2016.
 Inc..
Siegfried USA, LLC..............  81 FR 15567.......  March 23, 2016.
Patheon Pharmaceuticals, Inc....  81 FR 15571.......  March 23, 2016.
Navinta, LLC....................  81 FR 20418.......  April 7, 2016.
Patheon API Manufacturing, Inc..  81 FR 22122.......  April 14, 2016.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of these registrants to manufacture 
the applicable basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each of the company's maintenance of 
effective controls against diversion by inspecting and testing each 
company's physical security systems, verifying each company's 
compliance with state and local laws, and reviewing each company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed persons.

    Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18921 Filed 8-9-16; 8:45 am]
 BILLING CODE 4410-09-P